GlassScriptPhysician profile
James M Neff
NPI 1013992015
$994.44
in general payments reported to CMS, 2019-2025
18 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $546 · 2020: $369 · 2021: $80.35.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $185.31 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $170.81 | 2019-2020 | |
| Astellas Pharma US INC | $115.06 | 2019 | |
| Merck Sharp & Dohme LLC | $85.22 | 2019-2020 | |
| Novo Nordisk INC | $62.34 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $54.46 | 2019-2020 | |
| Lilly USA, LLC | $53.19 | 2020-2021 | |
| Amarin Pharma, INC. | $50.28 | 2020 | |
| Esperion Therapeutics, INC. | $44.05 | 2020-2021 | |
| Boston Scientific Corporation | $39.86 | 2019-2020 | |
| Glaxosmithkline, LLC. | $31.49 | 2019-2021 | |
| Hologic Sales and Service, LLC | $16.92 | 2021 | |
| Sanofi-Aventis U.S. LLC | $16.03 | 2019 | |
| Eisai INC. | $15.17 | 2020 | |
| Radius Health, INC. | $14.64 | 2019 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $14.23 | 2020 | |
| Abbvie INC. | $13.00 | 2020 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $12.38 | 2020 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Neff listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.